Literature DB >> 27672482

Gabapentin Abuse in a Patient with Comorbid Mood and Substance Use Disorders.

Oleg V Tcheremissine1, Durga Prasad Bestha1.   

Abstract

Entities:  

Year:  2016        PMID： 27672482      PMCID： PMC5022983     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN： 2158-8333


× No keyword cloud information.
  7 in total

Review 1.  Relative abuse liability of different benzodiazepines in drug abusers.

Authors:  R R Griffiths; B Wolf
Journal:  J Clin Psychopharmacol       Date:  1990-08       Impact factor: 3.153

Review 2.  Misuse and abuse of pregabalin and gabapentin: cause for concern?

Authors:  Fabrizio Schifano
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

3.  Individual differences in aggressive responding to intravenous flumazenil administration in adult male parolees.

Authors:  Oleg V Tcheremissine; Scott D Lane; Lori M Lieving; Howard M Rhoades; Sylvain Nouvion; Don R Cherek
Journal:  J Psychopharmacol       Date:  2005-11       Impact factor: 4.153

Review 4.  Gabapentin: Abuse, Dependence, and Withdrawal.

Authors:  Tracey L Mersfelder; William H Nichols
Journal:  Ann Pharmacother       Date:  2015-12-31       Impact factor: 3.154

5.  Abuse of Gabapentin is Associated with Opioid Addiction.

Authors:  Leo Bastiaens; James Galus; Cherise Mazur
Journal:  Psychiatr Q       Date:  2016-12

6.  Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability.

Authors:  J D Roache; R R Griffiths
Journal:  J Pharmacol Exp Ther       Date:  1987-12       Impact factor: 4.030

7.  Gabapentin Therapy in Psychiatric Disorders: A Systematic Review.

Authors:  Rachel K Berlin; Paul M Butler; Michael D Perloff
Journal:  Prim Care Companion CNS Disord       Date:  2015-10-22
  7 in total
  2 in total

1.  Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.

Authors:  Kirk E Evoy; Sarvnaz Sadrameli; Jillian Contreras; Jordan R Covvey; Alyssa M Peckham; Megan D Morrison
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

2.  Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population.

Authors:  Alyssa M Peckham; Kathleen A Fairman; David A Sclar
Journal:  Clin Drug Investig       Date:  2017-08       Impact factor: 2.859
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.